chlorpromazine has been researched along with Pantothenate Kinase-Associated Neurodegeneration in 1 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Pantothenate Kinase-Associated Neurodegeneration: A rare autosomal recessive degenerative disorder which usually presents in late childhood or adolescence. Clinical manifestations include progressive MUSCLE SPASTICITY; hyperreflexia; MUSCLE RIGIDITY; DYSTONIA; DYSARTHRIA; and intellectual deterioration which progresses to severe dementia over several years. (From Adams et al., Principles of Neurology, 6th ed, p972; Davis & Robertson, Textbook of Neuropathology, 2nd ed, pp972-929)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siegl, C | 1 |
Hamminger, P | 1 |
Jank, H | 1 |
Ahting, U | 1 |
Bader, B | 1 |
Danek, A | 1 |
Gregory, A | 1 |
Hartig, M | 1 |
Hayflick, S | 1 |
Hermann, A | 1 |
Prokisch, H | 1 |
Sammler, EM | 1 |
Yapici, Z | 1 |
Prohaska, R | 1 |
Salzer, U | 1 |
1 other study available for chlorpromazine and Pantothenate Kinase-Associated Neurodegeneration
Article | Year |
---|---|
Alterations of red cell membrane properties in neuroacanthocytosis.
Topics: Acanthocytes; Adolescent; Adult; Basal Ganglia; Calcium; Case-Control Studies; Cations, Divalent; Ch | 2013 |